Understanding changes in pre-clinical Alzheimer’s disease: Study finds two proteins impact brain activity differently

Amyloid-beta and tau proteins have long been associated with Alzheimer’s disease. The pathological buildup of these proteins leads to cognitive decline in people with the disease. How it does that, though, remains poorly understood.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup